US drugmaker Moderna applies for Emergency Use Authorisation (EUA)

  • IASbaba
  • December 4, 2020
  • 0
UPSC Articles
Print Friendly, PDF & Email

US drugmaker Moderna applies for Emergency Use Authorisation (EUA)

Part of: GS Prelims and GS-III – Sci & Tech

In news

  • US drugmaker Moderna said it was applying for emergency use authorisation for its Covid-19 vaccine. 
  • In India, Serum Institute of India, which is trialling a version of the AstraZeneca-Oxford vaccine, has said it expects to seek emergency use authorisation within the next two weeks.

Key takeaways

  • Vaccines, medicines, diagnostic tests and medical devices, require the approval of a regulatory authority before they can be administered. 
  • In India, the regulatory authority is the Central Drugs Standard Control Organisation (CDSCO).
  • For vaccines and medicines, approval is granted after an assessment of their safety and effectiveness, based on data from trials. 
  • This is a long process, designed to ensure that a medicine or vaccine is absolutely safe and effective.
  • In emergency situations, like COVID-19, regulatory authorities around the world have developed mechanisms to grant interim approvals if there is sufficient evidence to suggest a medical product is safe and effective.
  • Final approval is granted only after completion of the trials and analysis of full data; until then, emergency use authorisation (EUA) allows the medicine or the vaccine to be used on the public.

For a dedicated peer group, Motivation & Quick updates, Join our official telegram channel –

Subscribe to our YouTube Channel HERE to watch Explainer Videos, Strategy Sessions, Toppers Talks & many more…

Search now.....

Sign Up To Receive Regular Updates